4.7 Article

Sodium Phytate-Incorporated Gelatin-Silicate Nanoplatelet Composites for Enhanced Cohesion and Hemostatic Function of Shear-Thinning Biomaterials

期刊

MACROMOLECULAR BIOSCIENCE
卷 23, 期 1, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/mabi.202200333

关键词

embolization; hemostatic; Shear-thinning biomaterial; silicate nanoplatelet; sodium phytate

向作者/读者索取更多资源

Shear-thinning biomaterials based on gelatin-silicate nanoplatelets are being explored as an alternative treatment for vascular anomalies. The addition of sodium phytate additives improves the mechanical properties and injectability of the biomaterials while reducing immune responses. The optimized biomaterials show enhanced storage modulus and reduced injection force, making them suitable for minimally invasive therapies. Furthermore, the incorporation of phytate leads to accelerated blood coagulation, contributing to the prolonged durability of the biomaterials in coagulopathic patients.
Shear-thinning biomaterials (STBs) based on gelatin-silicate nanoplatelets (SNs) are emerging as an alternative to conventional coiling and clipping techniques in the treatment of vascular anomalies. Improvements in the cohesion of STB hydrogels pave the way toward their translational application in minimally invasive therapies such as endovascular embolization repair. In the present study, sodium phytate (Phyt) additives are used to tune the electrostatic network of SNs-gelatin STBs, thereby promoting their mechanical integrity and facilitating injectability through standard catheters. We show that an optimized amount of Phyt enhances storage modulus by approximately one order of magnitude and reduces injection force by approximate to 58% without compromising biocompatibility and hydrogel wet stability. The Phyt additives are found to decrease the immune responses induced by SNs. In vitro embolization experiments suggest a significantly lower rate of failure in Phyt-incorporated STBs than in control groups. Furthermore, the addition of Phyt leads to accelerated blood coagulation (reduces clotting time by approximate to 45% compared to controls) due to the contributions of negatively charged phosphate groups, which aid in the prolonged durability of STB in coagulopathic patients. Therefore, the proposed approach is an effective method for the design of robust and injectable STBs for minimally invasive treatment of vascular malformations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据